MGLN Key Statistics, Chart & Performance
The current stock price of MGLN is 94.99 null. In the past month the price increased by 0.58%. In the past year, price increased by 0.68%.
MGLN Latest News, Press Relases and Analysis
MGLN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | 15.75 | 299.75B | ||
| ELV | ELEVANCE HEALTH INC | 10.78 | 73.51B | ||
| HUM | HUMANA INC | 13.62 | 31.01B | ||
| CNC | CENTENE CORP | 9.49 | 18.84B | ||
| HQY | HEALTHEQUITY INC | 25.2 | 8.07B | ||
| MOH | MOLINA HEALTHCARE INC | 8.23 | 7.81B | ||
| ALHC | ALIGNMENT HEALTHCARE INC | N/A | 3.91B | ||
| PGNY | PROGYNY INC | 38.13 | 2.07B | ||
| CLOV | CLOVER HEALTH INVESTMENTS CO | N/A | 1.33B |
Related stock screener links
About MGLN
Company Profile
Magellan Health, Inc. engages in the business of healthcare management. The company is headquartered in Phoenix, Arizona and currently employs 9,000 full-time employees. The company went IPO on 2004-01-06. The firm provides managed care and pharmacy solutions for healthcare. The firm's segments include Healthcare, Pharmacy Management and Corporate. Its Healthcare includes carve-out management services for behavioral health, employee assistance plans (EAP) and other areas of specialty healthcare including diagnostic imaging, musculoskeletal management, cardiac and physical medicine. Its Pharmacy Management segment consists of products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Its Corporate segment consists of amounts not allocated to the Healthcare and Pharmacy Management segments. The firm provides services to health plans and other managed care organizations (MCOs), employers, labor unions, various military and governmental agencies and third party administrators (TPAs).
Company Info
MAGELLAN HEALTH INC
4801 E Washington St
Phoenix ARIZONA 85034 US
CEO: Kenneth J. Fasola
Employees: 9000
Phone: 18006421716.0
MAGELLAN HEALTH INC / MGLN FAQ
Can you describe the business of MAGELLAN HEALTH INC?
Magellan Health, Inc. engages in the business of healthcare management. The company is headquartered in Phoenix, Arizona and currently employs 9,000 full-time employees. The company went IPO on 2004-01-06. The firm provides managed care and pharmacy solutions for healthcare. The firm's segments include Healthcare, Pharmacy Management and Corporate. Its Healthcare includes carve-out management services for behavioral health, employee assistance plans (EAP) and other areas of specialty healthcare including diagnostic imaging, musculoskeletal management, cardiac and physical medicine. Its Pharmacy Management segment consists of products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Its Corporate segment consists of amounts not allocated to the Healthcare and Pharmacy Management segments. The firm provides services to health plans and other managed care organizations (MCOs), employers, labor unions, various military and governmental agencies and third party administrators (TPAs).
What is the stock price of MAGELLAN HEALTH INC today?
The current stock price of MGLN is 94.99 null.
What is the dividend status of MAGELLAN HEALTH INC?
MGLN does not pay a dividend.
What is the ChartMill rating of MAGELLAN HEALTH INC stock?
MGLN has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Can you provide the sector and industry classification for MAGELLAN HEALTH INC?
MAGELLAN HEALTH INC (MGLN) operates in the Health Care sector and the Health Care Providers & Services industry.
Is MAGELLAN HEALTH INC (MGLN) expected to grow?
The Revenue of MAGELLAN HEALTH INC (MGLN) is expected to grow by 8.27% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
MGLN Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to MGLN. When comparing the yearly performance of all stocks, MGLN turns out to be only a medium performer in the overall market: it outperformed 49.92% of all stocks.
MGLN Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to MGLN. MGLN has an excellent financial health rating, but there are some minor concerns on its profitability.
MGLN Financial Highlights
Over the last trailing twelve months MGLN reported a non-GAAP Earnings per Share(EPS) of 1.09. The EPS decreased by -67.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.26% | ||
| ROA | 9% | ||
| ROE | 15.61% | ||
| Debt/Equity | 0.27 |
MGLN Forecast & Estimates
6 analysts have analysed MGLN and the average price target is 96.9 null. This implies a price increase of 2.01% is expected in the next year compared to the current price of 94.99.
For the next year, analysts expect an EPS growth of 11.05% and a revenue growth 8.27% for MGLN